Stelios Papadopoulos serves as Executive at SGX PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Stelios Papadopoulos has executed 157 insider transactions totaling $32.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 14, 2007 involved purchasing 2,869 shares valued at $6.6K.
Stelios Papadopoulos currently holds 1,189,228 shares of SGX PHARMACEUTICALS, INC. (SGXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stelios Papadopoulos has been a net seller of SGXP stock. They have purchased $8.8M and sold $23.7M worth of shares.
Stelios Papadopoulos's most recent insider trade was on Sep 14, 2007, when they purchased 2,869 shares at $2.30 per share.
Get notified when new Form 4 filings are submitted
| $2.30 |
| Discretionary |
| Sep 5, 2007 | ANDS | $205.5K | Purchase | 89,333 | $2.30 | Discretionary |
| Aug 31, 2007 | ANDS | $73.1K | Purchase | 32,913 | $2.22 | Discretionary |
| Aug 17, 2007 | ANDS | $83.8K | Purchase | 38,989 | $2.15 | Discretionary |
| Feb 6, 2006 | SGXP | $0 | Conversion | 6,813 | $N/A | Discretionary |
| Feb 6, 2006 | SGXP | $0 | Conversion | 29,117 | $N/A | Discretionary |